ARScience Biotherapeutics appoints Gustavo Mahler as CEO

Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management

Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms

Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research

Orionis expands Novartis partnership in potential $1.4 billion molecular glue drug feal

Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact

MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies

ZoBio launches DEL platform to accelerate drug discovery for challenging targets

New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography

Breakthrough approval in prostate cancer for AstraZeneca therapy

The decision was driven by results from the Phase III CAPItello-281 trial,

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion

Evonik unveils probiotic advance in fight against antibiotic resistance

Evonik researchers say they have achieved a significant breakthrough with Ecobiol

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California